Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Greater China

BASF Bets on China Growth as Zhanjiang Site Targets €5 Billion in Sales by 2030

Basf (ETR:BAS) executives said the company’s new Zhanjiang Verbund site in Guangdong province has started operations successfully, positioning the German chemicals group for further growth in China while adding a major new production platform built around digitalization, feedstock flexibility and re

MarketBeat

‘The next China is still China’: McKinsey’s Joe Ngai and Nick Leung on why global business can’t write off the Chinese economy

“You can’t find another China. There’s no other China out there now," Greater China chair Joe Ngai says.

Fortune

VISTA GLOBAL EXPANDS GREATER CHINA FOOTPRINT WITH 32% ANNUAL TRAFFIC GROWTH

HONG KONG and SHANGHAI, May 21, 2026 /PRNewswire/ -- Vista, the world's leading private aviation group, earlier this week unveiled its new flagship Bombardier Global 8000 to media and key stakeholders through an exclusive tour across Hong Kong and Shanghai. This tour models key flight routes highly relevant in today's…

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

The U.S. created over 1,000 new millionaires per day in 2024

Mainland China added roughly 380 new millionaires per day, according to the UBS Global Wealth Report.

Fortune

Trump's victory could make life harder for Hong Kong—and that may be good news for Singapore's banks

Banks like Singapore's OCBC are poised to gain from Chinese investment into Southeast Asia—now potentially supercharged by a new Trump trade war.

Fortune

Turning Point Inks Licensing Pact For Gastrointestinal Cancers Candidate

Turning Point Therapeutics Inc (NASDAQ:TPTX) entered into an exclusive license agreement with LaNova Medicines Limited to develop and commercialize LM-302, in the U.S. and the rest of the world, excluding Greater China and South Korea. LM-302 is a novel antibody-drug conjugate (ADC) targeting Claudin18.2, a protein expressed in many gastrointestinal cancers, including gastric, gastroesophageal junction,…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.